World's Best Scientists 2026 revealed!
Future Microbiology
H-index 21

Future Microbiology

1746-0913

Published by: Future Medicine

https://www.futuremedicine.com/loi/fmb

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Microbiology 126 83 90 16

Additional Metrics

Number of Best Scientists*: 187
Documents by Best Scientists*: 190
Top 100 Ranked Scientists*: 8
SCIMAGO H-index: 107
SCIMAGO SJR: 0.539
Impact Factor: 2.4

Overview

Top Research Topics at Future Microbiology?

The journal primarily tackles Microbiology, Immunology, Virology, Virulence and Antibiotics. Issues in Microbiology were discussed, taking into consideration concepts from other disciplines like Biofilm, Staphylococcus aureus and Bacteria. Future Microbiology focused on Immunology research but expanded to cover Disease.

Virus is a key component of Virology research discussed in the journal. The featured Virulence research is covered under the field of Gene. Future Microbiology focuses on Antibiotics as well as the interrelated topic of Intensive care medicine.

The journal investigates Antibiotic resistance research which frequently intersects with Drug resistance.

  • Microbiology (38.33%)
  • Immunology (16.97%)
  • Virology (15.48%)

What are the most cited papers published in the journal?

  • Phage cocktails and the future of phage therapy (446 citations)
  • Pseudomonas aeruginosa biofilms in cystic fibrosis (414 citations)
  • Bacteriophage endolysins as novel antimicrobials (381 citations)

Research areas of the most cited articles at Future Microbiology:

The most cited articles mainly deal with areas of study such as Microbiology, Immunology, Virology, Antibiotic resistance and Virulence. The most cited articles hold forums on Microbiology that merge themes from other disciplines such as Biofilm and Bacteria. The journal articles facilitate discussions on Antibiotic resistance that incorporate concepts from other fields like Multiple drug resistance and Efflux.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Bacteria

The previous edition focused in particular on these issues:

The main research concerns discussed in the journal are Microbiology, Antibiotics, Internal medicine, Coronavirus disease 2019 (COVID-19) and Antimicrobial. Topics in Microbiology were tackled in line with various other fields like Bacteria, Biofilm, Klebsiella pneumoniae and Virulence. Antibiotics works presented in it have a specific focus on Antibiotic resistance.

The studies in Antibiotic resistance featured incorporate elements of Drug resistance and Staphylococcus aureus. The Antimicrobial research presented in it explores the relationship between Pseudomonas aeruginosa and the closely related topic of Cystic fibrosis, Levofloxacin and Ciprofloxacin. Topics in Virology explored in it were investigated in conjunction with research in Host (biology) and Disease.

The most cited articles from the last journal are:

  • Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: an emerging tool for studying the vectors of human infectious diseases. (3 citations)
  • COVID-19 pneumonia: do not leave the corticosteroids behind! (3 citations)
  • Clonal relatedness and plasmid profiling of extensively drug-resistant New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae clinical isolates. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Future Microbiology (based on the number of publications) are:

  • Didier Raoult (23 papers) absent at the last edition,
  • Ellen E. Stobberingh (11 papers) absent at the last edition,
  • Rosilene Fressatti Cardoso (11 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • Po-Ren Hsueh (11 papers) absent at the last edition,
  • Vera Ld Siqueira (10 papers) published 2 papers at the last edition, 1 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Future Microbiology (based on the number of publications) are:

  • National Institutes of Health (34 papers) absent at the last edition,
  • University of Amsterdam (26 papers) absent at the last edition,
  • Universidade Estadual de Maringá (24 papers) published 3 papers at the last edition, 3 less than at the previous edition,
  • Centre national de la recherche scientifique (24 papers) absent at the last edition,
  • Sao Paulo State University (22 papers) published 1 paper at the last edition, 4 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.82% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 10.89% were posted by at least one author from the top 10 institutions publishing in the journal. Another 5.94% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.81% of all publications and 64.36% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis.

    Jack D Sobel;Paul Nyirjesy

    (2021)
    56 Citations
  • Systemic mycoses: a potential alert for complications in COVID-19 patients.

    Gonzalo Segrelles-Calvo;Glauber R de S Araújo;Susana Frases

    (2020)
    49 Citations
  • Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: an emerging tool for studying the vectors of human infectious diseases.

    Jacques Sevestre;Adama Z Diarra;Maureen Laroche;Lionel Almeras

    (2021)
    49 Citations
  • Terpinen-4-ol attenuates quorum sensing regulated virulence factors and biofilm formation in Pseudomonas aeruginosa.

    Sunil K Bose;Monika Chauhan;Neelima Dhingra;Sanjay Chhibber

    (2020)
    47 Citations
  • Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV.

    Sarah Aherfi;Bruno Pradines;Christian Devaux;Stéphane Honore

    (2021)
    34 Citations
  • Ceftobiprole versus daptomycin in Staphylococcus aureus bacteremia: a novel protocol for a double-blind, Phase III trial.

    Kamal Hamed;Marc Engelhardt;Mark E Jones;Mikael Saulay

    (2020)
    30 Citations
  • Safety, immunogenicity and risk-benefit analysis of rVSV-ΔG-ZEBOV-GP (V920) Ebola vaccine in Phase I-III clinical trials across regions.

    Bache Emmanuel Bache;Martin P Grobusch;Selidji Todagbe Agnandji

    (2020)
    29 Citations
  • Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry: an emerging tool for studying the vectors of human infectious diseases.

    (2021)
    27 Citations
  • Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic

    (2021)
    24 Citations
  • Promising strategies for future treatment of Klebsiella pneumoniae biofilms.

    Nelson G de Oliveira Júnior;Nelson G de Oliveira Júnior;Octávio L Franco;Octávio L Franco

    (2020)
    21 Citations

Related Online Degrees & Career Pathways

For those interested in healthcare but seeking alternatives to medical school, there are several accessible and flexible online degree options. Prospective students can explore easy to get into nursing programs that provide a practical path into nursing with less competitive admissions. These programs often offer hands-on experience and foundational knowledge crucial for healthcare careers.

For individuals aiming to step into leadership roles within healthcare systems, pursuing a health administration degree online can be an ideal choice. Accelerated formats enable quicker completion times, helping students enter the workforce faster while managing their schedules effectively.

Affordability remains a key consideration for many students. Exploring healthcare administration degree programs that offer quality education at a lower cost ensures wider access to vital healthcare management skills without compromising on education standards.

Finally, for nurses looking to advance clinical expertise, online fnp programs provide a flexible pathway to becoming Family Nurse Practitioners. These programs combine convenience with rigorous training, supporting career growth in high-demand roles across diverse healthcare settings.

Best Scientists Contributing to This Journal

Recently Published Articles